Client
- Name
- NOVARTIS, INC.
- Description
- Multinational biopharmaceutical company
- Location
- District of Columbia · United States of America
Registrant
- Firm
- FORBES-TATE
- Description
- Government Relations Firm.
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
6 issuesHealth Issues
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program; Issues related to the implementation of Consolidated Appropriations Act, 2024 (PL 118-42); Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); H.R. 5547/S. 476 - Maintaining Investments in New Innovation Act.
LobbyistsELIZABETH GREER · JEFFREY FORBES · JEFFREY STRUNK · DERRICK M WHITE · CYNTHIA BROWN · KRISTINA DUNKLIN · BARRETT THORNHILL · mr MICHAEL ALEXANDER WILLIAMS
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medicare/Medicaid
Issues related to prescription drug pricing; Issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to pharmacy benefit managers; H.R. 5547/S. 476 - Maintaining Investments in New Innovation Act.
LobbyistsELIZABETH GREER · JEFFREY FORBES · JEFFREY STRUNK · DERRICK M WHITE · CYNTHIA BROWN · KRISTINA DUNKLIN · BARRETT THORNHILL · mr MICHAEL ALEXANDER WILLIAMS
TargetedSENATE · HOUSE OF REPRESENTATIVES
Trade (domestic/foreign)
Issues related to prescription drug pricing; Issues related to World Trade Organization IP waiver; Issues related to pharmaceutical intellectual property; Issues related to international trade.